SCHEMBL6152406

SCHEMBL6152406

N=Cc1ccccc1O.[Cu]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.54
TRIM33 Q9UPN9 1/20 0.54
CDK4 P11802 1/20 0.52
CCND1 P24385 1/20 0.52
TRPA1 O75762 1/20 0.48
CA2 P00918 8/20 0.46
CA12 O43570 7/20 0.46
CA9 Q16790 5/20 0.46
NFKB1 P19838 3/20 0.46
KDM4E B2RXH2 3/20 0.46
SIRT2 Q8IXJ6 1/20 0.46
JUN P05412 1/20 0.46
NFE2L2 Q16236 1/20 0.46
MAPT P10636 3/20 0.45
CA4 P22748 2/20 0.45
LMNA P02545 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 2/20 0.45
NPC1 O15118 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29419973 0.97
SCHEMBL49998 0.97
SCHEMBL31345759 0.95 TRIM24 (0.54) TRIM24TRIM33CDK4CCND1TRPA1
SCHEMBL28612061 0.95 TRIM24 (0.54) TRIM24TRIM33CDK4CCND1TRPA1
SCHEMBL28803772 0.95 TRIM24 (0.54) TRIM24TRIM33CDK4CCND1TRPA1
SCHEMBL7172431 0.95 TRIM24 (0.54) TRIM24TRIM33CDK4CCND1TRPA1
SCHEMBL11721447 0.95 TRIM24 (0.54) TRIM24TRIM33CDK4CCND1TRPA1
SCHEMBL1471372 0.95 TRIM24 (0.54) TRIM24TRIM33CDK4CCND1TRPA1
SCHEMBL6035511 0.95 TRIM24 (0.54) TRIM24TRIM33CDK4CCND1TRPA1
SCHEMBL28990189 0.95 TRIM24 (0.54) TRIM24TRIM33CDK4CCND1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6852871-B2 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2005-02-08 US claimed
US-20030233003-A1 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY, LIMITED 2003-12-18 US claimed
EP-1371631-A1 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-12-17 EP claimed
CN-1309723-C Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL CO (JP) 2007-04-11 CN disclosed
CN-1309723-C Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL CO (JP) 2007-04-11 CN disclosed
US-6852871-B2 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2005-02-08 US disclosed
US-6852871-B2 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2005-02-08 US disclosed
US-6852871-B2 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2005-02-08 US disclosed
EP-1038669-B1 Method of producing directly imageable waterless planographic printing plate TORAY INDUSTRIES (JP) 2005-01-26 EP disclosed
CN-1467211-A Method for producing optically active salicylaldimine copper complex ס�ѻ�ѧ��ҵ��ʽ���� 2004-01-14 CN disclosed
CN-1467211-A Method for producing optically active salicylaldimine copper complex ס�ѻ�ѧ��ҵ��ʽ���� 2004-01-14 CN disclosed
US-20030233003-A1 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY, LIMITED 2003-12-18 US disclosed
US-20030233003-A1 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY, LIMITED 2003-12-18 US disclosed
US-20030233003-A1 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY, LIMITED 2003-12-18 US disclosed
EP-1371631-A1 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-12-17 EP disclosed
EP-1371631-A1 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-12-17 EP disclosed
EP-1371631-A1 Method for producing optically active salicylaldimine copper complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-12-17 EP disclosed
US-6284433-B1 IMAGEWISELY IRRADIATING PRECURSOR OF PRINTING PLATE WITH LASER BEAM, PRE-TREATING PRECURSOR WITH GLYCOL COMPOUND AND/OR A GLYCOL ETHER COMPOUND; REMOVING INK REPELLENT LAYER WHEREIN HEAT SENSITIVE LAYER IS PARTIALLY LEFT ON PRINTING PLATE TORAY INDUSTRIES, INC. (JP) 2001-09-04 US disclosed
EP-1038669-A1 Method of producing directly imageable waterless planographic printing plate TORAY INDUSTRIES, INC. (JP) 2000-09-27 EP disclosed
US-4013620-A OXIDATION RESISTANCE AMERICAN CYANAMID COMPANY (US) 1977-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030233003-A1 Method for producing optically active salicylaldimine copper complex ADH1A, ALDH3A1, ADH1C TRIM24 1934/4885TRIM33 2886/4885CDK4 3003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.